Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey Bro!
Archie,
Thanks on for Huskers! And I almost went to N.D. <grin>.
just try and got to www.clearstation.com and click on the find recommends and use Cornhusker - something about the cookie on my puter here at work.
Ok I'm really going to open myself up, go and bad you can see my recommend list at clearstation.com I'd be: Cornhusker
http://www.clearstation.com/cgi-bin/drill_open_positions?usernm=Cornhusker&PortfolioName=recomme...
Mark HWL = Howling With Laughter eom
Arch..
Yep big time, former fan and jock, born and raised right there in Lincoln. :)
If we can just manage to stay afloat. HWL
here's the deal fellas, until CSCO lives a little I'm dead in the H2O. Down about $6k in CSCO. that's about 8 bucks a share for me. anybody say ouch!
Ok I'm here, now what? Lost most my $ to CSCO! :)
Wow - talk about knocking my socks off, guess you never know who is a believing or who isn't!
Peace
thanks my friends
Anyone still here?
I second the comments by Mark! Also note BB stocks are the most easily manipulated. It takes hands of steel to hold true in difficult times.
Howdy all! Back home now, might have more time to get back on track soon as I get caught-up on work! <grin>
darn!
What kind of office is in Vegas for CHAG? Maybe I can drop in next week, if I get some free time from Infocomm
OT You Think A Gallon Of Gas Is Expensive?
Makes one think, and puts things in perspective.
Diet Snapple 16oz $1.29 $10.32 per gallon
Lipton Ice Tea 16oz $1.19 $9.52 per gallon
Gatorade 20oz $1.59 $10.17 per gallon
Ocean Spray 16oz $1.25 $10 .00 per gallon
Brake Fluid 12oz $3.15 $33.60 per gallon
Vick's Nyquil 6oz $8.35 $178.13 per gallon
Pepto Bismol 4oz $3.85 $123.20 per gallon
Whiteout 7oz $1.39 $25.42 per gallon
Scope 1.5oz $0.99 $84.48 per gallon
And this is the REAL KICKER......
Evian water 9oz for $1.49 $21.19 per gallon
$21.19 FOR WATER!
....and the buyers don't even know the source.
So, the next time you're at the pump, be glad your car doesn't run on
Nyquil, or Scope, or Whiteout.
Oil refineries are making a mint on tight gasoline supplies
http://www.fool.com/news/2001/vlo010604.htm
Interesting regarding
http://www.businessweek.com/magazine/content/01_21/b3733109.htm
PETROLEUM SERVICES +166%
COAL, OIL & GAS +86%
millions
EXXON MOBIL $4,960
CHEVRON 1,600
For Notes From "Speaking the Truth in Love" (Live Call-In Bible Program
http://www.public.usit.net/driggs/
Brief Exhortations & Applications From Various Verses
http://www.public.usit.net/driggs/briefvs.htm
Thursday May 24, 10:49 am Eastern Time
Press Release
New Study Confirms Broader Role for Vasomedical's EECP Therapy as Primary Treatment for Angina
Data presented at the British Cardiac Society's annual meeting show that candidates for elective bypass surgery or angioplasty respond well to primary treatment with EECP®.
WESTBURY, NY--(BW HealthWire)--May 24, 2001-- Vasomedical, Inc. (Nasdaq: VASO - news) announced today that a study presented at this week's annual meeting of the British Cardiac Society in Manchester, UK May 22-24, 2001 confirms that EECP may be used as an initial treatment strategy for patients suffering from angina or chest pain despite their eligibility for elective bypass surgery or angioplasty and that these patients benefit from primary treatment with EECP in much the same way as their sicker ``no option'' counterparts, most of whom no longer respond to medication or are poor candidates for these invasive procedures.
Commenting on the study, Charles P. Fitzgerald, MD, Medical Director of the Heart Care Clinic in Little Rock, AK and lead author of the study, stated, ``I think what this study bears out is that it is reasonable to use EECP as a primary treatment strategy for patients with coronary artery disease and stable angina, and to reserve invasive revascularization procedures for those who do not respond to EECP. Of course, the amount and duration of benefit as well as the impact on morbidity, mortality and resource utilization versus traditional revascularization still needs to be further investigated.''
The study, presented today in Manchester by Charles P. Fitzgerald, MD and entitled, Primary Utilization to Improve Myocardial Perfusion with Enhanced External Counterpulsation Revascularization (PUMPER) examined 3,037 consecutive patients entered into the International EECP Patient Registry (IEPR) at the University of Pittsburgh Graduate School of Public Health, Department of Epidemiology. The study compared 188 patients who had never undergone bypass surgery or angioplasty, but who, at the time of enrollment, were considered good candidates for such procedures, yet chose EECP as their primary revascularization therapy, to a control group of 2,849 patients who had previously undergone coronary bypass or angioplasty and/or were no longer good candidates for such procedures. Prior to treatment with EECP, 60.1% of patients with no prior revascularization were categorized as having class III or IV angina, the two most severe classifications as defined by the Canadian Cardiovascular Society, whose angina scale is an accepted tool for measuring the severity of chest pain. This figure fell to 16% at the end of treatment. In the control group, 81.9 % of patients were categorized as class III or IV prior to treatment. Following treatment this figure fell to 26.4%. The study also showed quality of life improvements in both groups as well as a significant decline in or discontinuation of nitroglycerine use.
According to Douglas A. Goldman, Vice President of Marketing & Business Development for Vasomedical, ``This latest study supports what we at Vasomedical have seen in practices across the United States, namely that cardiologists are offering EECP to patients who have been diagnosed with coronary artery disease, but opt to forgo the more traditional surgical or cath lab-based treatment methods. As routine prescribing of EECP for stable angina patients grows, so will the patient base within our core angina market.''
Another study on EECP also presented at this year's meeting of the British Cardiac Society entitled, ``The Improvements in Exercise Tolerance Post-Enhanced External Counterpulsation in Patients with Chronic Refractory Angina are Related to Diastolic Augmentation'' by lead author Angela S. Brown, MD of the Department of Cardiology at Beaumont Hospital in Dublin, Ireland showed a dramatic reduction in angina among the 40 patients studied and a significant improvement in exercise duration. Moreover, among the 30 patients for whom one-year follow-up data were available, there was a significant reduction in the number of in-patient hospital days during the first year following treatment compared to the number of in-patient days in the year prior to beginning EECP treatment (14.5 days v. 7.8 days). This is the first study reporting an economic benefit of EECP to the healthcare system. The data reported in this study provide independent confirmation of benefits of EECP seen in similar studies at the State University of New York at Stony Brook as well as Mayo Clinic.
EECP® is a noninvasive, outpatient therapy for the treatment of diseases of the cardiovascular system. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and may restore systemic vascular function. EECP® is currently indicated for use in patients with stable or unstable angina, acute myocardial infarction and cardiogenic shock. The company is actively engaged in research to determine potential benefits of EECP® therapy in the management of other major vascular disease states, such as congestive heart failure and diabetes.
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting external counter pulsation systems based on the Company's proprietary technology currently indicated for use in cases of angina, cardiogenic shock and acute myocardial infarction. EECP® is a registered trademark for Vasomedical's enhanced external counterpulsation system. This system is now in use at major medical centers, including the Beth Israel Medical Center - New York City, Christ Hospital and Medical Center, the Cleveland Clinic, Johns Hopkins, JFK Medical Center-Atlantis, FL, Mayo Clinic, the Miami Heart Institute, the Ochsner Foundation Hospital, the Texas Heart Institute, and University Hospital at UMDNJ/New Jersey Medical School as well as medical centers affiliated with Columbia University, State University of New York at Stony Brook, the University of Pittsburgh, the University of California at San Diego, the University of California at San Francisco, University of Florida at Gainesville, and the University of Virginia. The Company provides hospitals, clinics and private practices with EECP® equipment, treatment guidance and a staff training and maintenance program designed to provide optimal patient outcomes. Additional information is available on the Company's website at www.vasomedical.com.
-0- Except for historical information contained in this release, the matters discussed are forward looking statements that involve risks and uncertainties. When used in this release, words such as ``anticipate,'' ``believe,'' ``estimate,'' ``expect'' and ``intend'' and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to revise any forward-looking statements as a result of future events or developments.
Wednesday May 23, 1:36 pm Eastern Time
Press Release
Vasomedical Recognized as One of the Top Public Companies On Long Island
WESTBURY, N.Y.--(BW HealthWire)--May 23, 2001--Vasomedical, Inc. (Nasdaq: VASO - news) announced today that it was among the winners of the Sixth Annual Long Island Top Public Company Awards sponsored by the tax and consulting firm KMPG LLP, Long Island Business News, and Hofstra University.
The awards recognized outstanding achievements made last year by leading companies based in Nassau and Suffolk counties in New York State. Specific honors were awarded in five categories, including Share Price Appreciation, Revenue Growth, Largest Market Capitalization, Largest Increase in Market Capitalization, and Largest Increase in Employees. Vasomedical was among the top five winners in the categories for Largest Increase in Revenue and Largest Share Appreciation, with a 128% increase in FY2000 revenues and in a 126% increase in share appreciation for the calendar year ending December 31, 2000. The honors were awarded at a luncheon on held at the campus of Hofstra University on May 22nd.
``We are pleased to have been recognized as one of the Top Public Companies on Long Island,'' said D. Michael Deignan, President and CEO of Vasomedical. ``This award reflects the success we've achieved in advancing the validation of EECP® therapy as a treatment for angina, and in accelerating its adoption among cardiologists. With recent data supporting the sustained benefit of EECP at two years following treatment, the initiation of the PEECHTM trial into the efficacy of EECP in treating Congestive Heart Failure, and the expansion of our marketing efforts in the European Union, we expect this acceleration to continue. This award puts us in the company of some of the largest corporations in the country, including Comverse Technology, Cablevision Systems, and Computer Associates, and we are honored to be included in such an exclusive group. These awards speak highly of the business environment here on Long Island, from which we derive significant support from our investor base.''
EECP® is a noninvasive, outpatient therapy for the treatment of diseases of the cardiovascular system. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and may restore systemic vascular function. EECP is currently indicated for use in patients with stable or unstable angina, acute myocardial infarction and cardiogenic shock. The company is actively engaged in research to determine potential benefits of EECP therapy in the management of other major vascular disease states including diabetes.
Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting external counter pulsation systems based on the Company's proprietary technology currently indicated for use in cases of angina, cardiogenic shock and acute myocardial infarction. EECP® is a registered trademark for Vasomedical's enhanced external counterpulsation system. This system is now in use at major medical centers, including the Beth Israel Medical Center - New York City, Christ Hospital and Medical Center, the Cleveland Clinic, Johns Hopkins, JFK Medical Center-Atlantis, FL, Mayo Clinic, the Miami Heart Institute, the Ochsner Foundation Hospital, the Texas Heart Institute, and University Hospital at UMDNJ/New Jersey Medical School as well as medical centers affiliated with Columbia University, State University of New York at Stony Brook, the University of Pittsburgh, the University of California at San Diego, the University of California at San Francisco, University of Florida at Gainesville, and the University of Virginia. The Company provides hospitals, clinics and private practices with EECP® equipment, treatment guidance and a staff training and maintenance program designed to provide optimal patient outcomes. Additional information is available on the Company's website at www.vasomedical.com.
Except for historical information contained in this release, the matters discussed are forward looking statements that involve risks and uncertainties. When used in this release, words such as ``anticipate,'' ``believe,'' ``estimate,'' ``expect'' and ``intend'' and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to revise any forward-looking statements as a result of future events or developments
OT: What do you guys manybe know about this:
EVPO.OB
NAMPA, Idaho, May 18 /PRNewswire/ -- Environmental Oil Processing Technology Corporation (OTC Bulletin Board: EVOP - news) announced today that Sierra Pacific Power Company (NYSE: SRP - news) is negotiating a contract to purchase electric power generated from Environmental Oil's 30 megawatt power plant that will be built in Storey County, Nevada. The contract to supply northern Nevada consumers will begin on August 1, 2001 and end on December 31, 2002, at which time the contract is renewable.
What do you guys think about the energy plan and CHAG??
WSNC on LYCOS
(OTC:CHAG) Oil and gas company talks live about future for oil and Gas Production. CHAG recently announced a major milestone - "Big Bertha," the largest well on its Kansas Property is now online. Find out what's happening next! Tomorrow at 3:00pm EST
(OTC:PLRP) Pacel Corp. CEO talks business - Monday, 5/12
http://talkradio.lycos.com/talkradio/lycos/showguide/sg_tjbio.asp?jockeyid=4053
SAO PAULO, Brazil (AP) - Government officials urged ranchers in southern Brazil on Tuesday to slaughter thousands of cattle after 11 cases of highly contagious foot-and-mouth disease were discovered over the weekend. Officials were already planning to vaccinate millions of cattle in the region, near the border with Uruguay and Argentina. Now, they're asking farms in a two-mile radius of the ranch where the disease was discovered to kill and incinerate their animals. "We are trying to convince ranchers in and around the affected area to slaughter their herds," an Agriculture Ministry official said on condition of anonymity. He said thousands of head of cattle could be slaughtered, but did not have an exact number. If the farmers refuse the slaughter proposal, then their animals would be included among those to be vaccinated, the official said.
Ola.. what's up..
why you using Dancing's ID? bored?
PORTLAND, Ore. (AP) - A significant bulge in the earth's crust has developed over the past four years near volcanoes in central Oregon, but it's not clear whether it could mean a volcanic eruption any time soon, geologists said Tuesday. The bulge - nine to 12 miles across and about 4 inches high - was detected by satellite radar, said Willie Scott, a USGS scientist at the agency's volcano lab in Vancouver, Wash. "Because it's a volcanic area and there's been a long history of volcanic activity in that part of the Cascades, it's possible it might be magma, or molten rock, moving deep underground," Scott said. The bulge is located near the Three Sisters, a trio of volcanoes at the center of the Cascade Range in Oregon. The last major eruption in the Pacific Northwest occurred in May 1980, when Mount St. Helens blasted off about 1,300 feet of its top
Wait until you read this!! LOL no pictures involved....
http://fohweb.macarthur.uws.edu.au/podiatry/boobs.jpg
what's da address again?? Need to BM it! eom
this is coming from my hp jornada
LOL!!!
Hey Lisa! How you do'n?
National Day of Prayer - May 3, 2001
Let's make an effort to do this!! ONE NATION UNDER GOD
Psalms 33:12 - "Blessed is the nation whose God is the Lord..."
Our Father and Our God,
We praise You for Your goodness to our nation, giving us blessings far beyond what we deserve.
Yet we know all is not right with America. We deeply need a moral and spiritual renewal to help us meet the many problems we face.
Convict us of sin. Help us to turn to You in repentance and faith. Set our feet on the path of Your righteousness and peace.
We pray today for our nation's leaders. Give them the wisdom to know what is right, and the courage to do it.
You have said, "Blessed is the nation whose God is the Lord." May this be a new era for America, as we humble ourselves and acknowledge You alone as our Savior and Lord.
This we pray in Your holy name, Amen.
Prayer for the Nation
Written by Billy Graham
National Day of Prayer - May 3, 2001
Let's make an effort to do this!! ONE NATION UNDER GOD
Psalms 33:12 - "Blessed is the nation whose God is the Lord..."
Our Father and Our God,
We praise You for Your goodness to our nation, giving us blessings far beyond what we deserve.
Yet we know all is not right with America. We deeply need a moral and spiritual renewal to help us meet the many problems we face.
Convict us of sin. Help us to turn to You in repentance and faith. Set our feet on the path of Your righteousness and peace.
We pray today for our nation's leaders. Give them the wisdom to know what is right, and the courage to do it.
You have said, "Blessed is the nation whose God is the Lord." May this be a new era for America, as we humble ourselves and acknowledge You alone as our Savior and Lord.
This we pray in Your holy name, Amen.
Prayer for the Nation
Written by Billy Graham
NATIONAL DAY OF PRAYER, 2001
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA
A PROCLAMATION
Turning to prayer in times of joy and celebration, strife and tragedy is an integral part of our national heritage. When the first settlers landed on the rocky shores of the New World, they celebrated with prayer, and the practice has continued through our history. In 1775, the Continental Congress asked the citizens of the colonies to pray for wisdom in forming a Nation. General George Washington, encamped at Valley Forge, also sought God's guidance as Americans fought for their independence. The faith of our Founding Fathers established the precedent that prayers and national days of prayer are an honored part of our American way of life.
Continuing in that tradition, many of the men and women who have served at the highest levels of our Nation also have turned to prayer seeking wisdom from the Almighty. President Lincoln, who proclaimed a day of "humiliation, fasting, and prayer" in 1863, once stated: "I have been driven many times to my knees by the overwhelming conviction that I had nowhere else to go. My own wisdom, and that of all about me, seemed insufficient for the day." Today, millions of Americans continue to hold dear that conviction President Lincoln so eloquently expressed. Gathering in churches, synagogues, mosques, temples, and homes, we ask for strength, direction, and compassion for our neighbors and ourselves.
The theme of the 2001 National Day of Prayer is "One Nation Under God." In a prayer written specially for the occasion, Americans are asked to pray for "a moral and spiritual renewal to help us meet the many problems we face." Special observances are scheduled for all 50 States, with local volunteers planning a variety of activities including prayer breakfasts, concerts, rallies, and student gatherings. These events will bring people of all faiths together, each according to his or her own beliefs, to give thanks to the Almighty and to ask for strength and guidance.
The Congress, by Public Law 100-307, has called on our citizens to reaffirm the role of prayer in our society and to honor the religious diversity our freedom permits by recognizing annually a "National Day of Prayer."
NOW, THEREFORE, I, GEORGE W. BUSH, President of the United States of America, by virtue of the authority vested in me by the Constitution and laws of the United States of America, do hereby proclaim May 3, 2001, as a National Day of Prayer. I encourage the citizens of our Nation to pray each in his or her own manner, seeking God's blessings on our families and government officials and personal renewal, moral awakening, and a new spirit of harmony across our land. I urge all Americans to join in observing this day with appropriate programs, ceremonies, and activities.
IN WITNESS WHEREOF, I have hereunto set my hand this twenty-seventh day of April, in the year of our Lord two thousand one, and of the Independence of the United States of America the two hundred and twenty-fifth.
GEORGE W. BUSH
General..
I'm a home grown husker to the core! born and raised in Lincoln. Moved away but Big Red still in my blood! Diehard!